Design, synthesis, and biological evaluation of novel napabucasin-melatonin hybrids as potent STAT3 inhibitors

被引:9
作者
Zhang, Chong [1 ]
Yang, Limin [1 ]
Yang, Xiaojuan [2 ]
Gao, Qinghe [1 ]
Qu, Yan [3 ]
Wu, Liqiang [1 ]
机构
[1] Xinxiang Med Univ, Sch Pharm, Xinxiang 453003, Peoples R China
[2] Xinxiang Univ, Sch Pharm, Xinxiang 453003, Peoples R China
[3] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang 453003, Peoples R China
基金
中国国家自然科学基金;
关键词
Napabucasin; Melatonin; STAT3; Antitumor; TRANSCRIPTION FACTOR STAT3; SMALL-MOLECULE INHIBITOR; SIGNAL TRANSDUCER; CANCER; ACTIVATOR; BREAST; DERIVATIVES; DISCOVERY; CELLS;
D O I
10.1016/j.bioorg.2023.106541
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The current work developed diverse novel napabucasin-melatonin hybrids as potent STAT3 inhibitors. Several biological studies have suggested many compounds demonstrating potent inhibition against different tumor cells. Among these, compound 7e depicted enhanced inhibition against HepG2, MDA-MB-231, and A549 cells than napabucasin, with IC50 values of 1.06, 1.38, and 1.3 mu M, respectively. Based on fluorescence polarization analysis, compound 7e was bound to the SH2 domain in STAT3, with an IC50 value of 12.95 mu M. Molecular docking further confirmed the 7e binding mode inside the SH2 domain of STAT3. Further mechanistic studies indicated that 7e inhibited the activation of STAT3 (Y705), and thus reduced the expression of STAT3 down-stream genes (CyclinD1, Bcl-2 and c-Myc) instead of affecting p-STAT1 expression. Meanwhile, the phosphory-lation levels of its upstream kinases JAK2 and bypass kinase Erk1/2 remain unaffected. Simultaneously, 7e induced cancer cell apoptosis in a concentration-dependent manner. Significantly, 20 mg/kg (i.p.) compound 7e suppressed the mouse HepG2 xenograft development in vivo without body weight loss, suggesting that it could be an effective antitumor agent.
引用
收藏
页数:13
相关论文
共 50 条
[41]   Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors [J].
Yu, Wei ;
Cheng, Li Peng ;
Pang, Wan ;
Guo, Ling Ling .
BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 57
[42]   Design, synthesis, and comprehensive evaluation of novel imidazole-chromone hybrids as potent cholinesterase and α-glucosidase inhibitors [J].
Khalfaoui, Massaab ;
Frites, Wahiba ;
Mermer, Arif ;
Kisa, Dursun ;
Yildirim, Buket ;
Chouiter, Mohamed I. ;
Silva, Artur M. S. ;
Boulebd, Houssem .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 297
[43]   Novel indolotacrine hybrids as acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and molecular docking studies [J].
Babaee, Saeed ;
Zolfigol, Mohammad Ali ;
Chehardoli, Gholamabbas ;
Faramarzi, Mohammad Ali ;
Mojtabavi, Somayeh ;
Akbarzadeh, Tahmineh ;
Hariri, Roshanak ;
Rastegari, Arezoo ;
Homayouni Moghadam, Farshad ;
Mahdavi, Mohammad ;
Najafi, Zahra .
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2023, 20 (05) :1049-1060
[44]   Novel inhibitors of the STAT3 signaling pathway: an updated patent review (2014-present) [J].
Wang, Feng ;
Cao, Xin-Yu ;
Lin, Guo-Qiang ;
Tian, Ping ;
Gao, Dingding .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (06) :667-688
[45]   Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study [J].
Ghafary, Shahrzad ;
Najafi, Zahra ;
Mohammadi-Khanaposhtani, Maryam ;
Nadri, Hamid ;
Edraki, Najmeh ;
Ayashi, Neda ;
Larijani, Bagher ;
Amini, Mohsen ;
Mahdavi, Mohammad .
ARCHIV DER PHARMAZIE, 2018, 351 (10)
[46]   Synthesis and biological evaluation of new N-alkylcarbazole derivatives as STAT3 inhibitors: Preliminary study [J].
Saturnino, Carmela ;
Palladino, Chiara ;
Napoli, Mariagrazia ;
Sinicropi, Maria Stefania ;
Botta, Antonio ;
Sala, Marina ;
de Prati, Alessandra Carcereri ;
Novellino, Ettore ;
Suzuki, Hisanori .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 60 :112-119
[47]   Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors [J].
Zhang, Bei ;
Huang, Yue ;
Zhang, Si-Rui ;
Huang, Meng-Xing ;
Zhang, Chen ;
Luo, Hai-Bin .
BIOORGANIC CHEMISTRY, 2021, 114
[48]   Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors [J].
Odeh, Dana M. ;
Allam, Heba Abdelrasheed ;
Baselious, Fady ;
Mahmoud, Walaa R. ;
Odeh, Mohanad M. ;
Ibrahim, Hany S. ;
Abdel-Aziz, Hatem A. ;
Mohammed, Eman R. .
DRUG DEVELOPMENT RESEARCH, 2024, 85 (03)
[49]   Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors [J].
Zhang, Xiangyu ;
Huang, Hailan ;
Zhang, Ziheng ;
Yan, Jiangkun ;
Wu, Tianxiao ;
Yin, Wenbo ;
Sun, Yixiang ;
Wang, Xinran ;
Gu, Yanting ;
Zhao, Dongmei ;
Cheng, Maosheng .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 220
[50]   Synthesis and evaluation of naphthalene derivatives as potent STAT3 inhibitors and agents against triple-negative breast cancer growth and metastasis [J].
Yang, Zhengyan ;
Xu, Hongyun ;
Yang, Yupo ;
Duan, Chaoqun ;
Zhang, Pai ;
Wang, Yang ;
Fu, Kai ;
Shen, Yonghong ;
Xu, Marvin Xuejun .
BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (02) :255-267